Table 5.
Side effects of the three types of COVID19 vaccine
Variable | First dose of COVID19 vaccine |
Second dose of COVID19 vaccine |
|||||
---|---|---|---|---|---|---|---|
Pfizer N = 441 | AstraZeneca N = 358 | Sinopharm N = 287 | P value | Pfizer N = 175 | Sinopharm N = 124 | P value | |
Presence of symptoms | 409(92.7) | 330 (92.2) | 237 (82.6) | <0.001 | 159(90.8) | 57 (45.9) | 0.034 |
Require hospitalization | 0(0.0) | 0(0.0) | 0 (0.0) | - | 1 (0.5) | 1 (0.8) | 0.085 |
Onset of symptoms | 0.012 | <0.001 | |||||
Immediately | 46 (10.4) | 20(5.6) | 29 (10.1) | 16 (9.1) | 9 (7.2) | ||
1st day | 321(72.8) | 301(84.1) | 159 (55.4) | 134 (76.5) | 53 (42.7) | ||
1st week | 31(7.0) | 17(4.7) | 20 (7.0) | 12 (6.8) | 9 (7.2) | ||
2nd week | 5(1.1) | 2(0.6) | 3 (1.0) | 10 (5.7) | 20 (16.4) | ||
3rd week | 1(0.2) | 1(0.3) | 2 (0.7) | 1 (0.5) | 0 (0.0) | ||
>30 days | 0(0.0) | 0(0.0) | 0(0.0) | 0(0.0) | 0 (0.0) | ||
Duration of symptoms (days)Mean (SD) | 2.59(3.6) | 1.67(0.57) | 2.02(1.67) | 0.31 | 2.56(3.6) | 3.32(4.6) | 0.33 |
Min-Max | 0–30 | 0–30 | 0–10 | 0–30 | 0–21 |
SD: standard deviation.